[Treatment of mucositis pain: News and prospects].
[Treatment of mucositis pain: News and prospects].
Bull Cancer. 2019 Jun 06;:
Authors: Guerrini-Rousseau L, Marec-Berard P, Bolle S, Laurent S
Abstract
Mucositis, an acute inflammation of the digestive mucosa, is one of the main toxicities secondary to oncological treatments. Among its consequences, mucositis-related pain is an important complication due to its intensity and repercussion, especially on quality of life. Treatment of pain plays a central role in management of mucositis. It must be multimodal, combining local and general opioid or non-opioid treatments, adapted to pain intensity and based on international recommendations updated in 2014. A systemic analgesic treatment with morphine with a patient-controlled analgesia device is often necessary in severe mucositis. In case of insufficient analgesia, use of co-analgesics (paracetamol, ketamine, anticonvulsants, and antidepressants) can improve analgesic control and reduce morphine doses. Non-drug strategies (distraction, relaxation, hypnosis) and preventive measures must be a major concern. Among them, laser therapy using a low power athermal laser beam, is a promising therapeutic strategy whose effectiveness is based on its analgesic, anti-inflammatory, and healing properties. Despite many available studies, there is a limited number of clinically effective therapies. New therapeutic agents for the prevention and treatment of mucositis and its pain, based on the biologica...
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Guerrini-Rousseau L, Marec-Berard P, Bolle S, Laurent S Tags: Bull Cancer Source Type: research
More News: Cancer | Cancer & Oncology | Laser Therapy | Morphine | Pain | Pain Management | Science | Study | Toxicology